Loading clinical trials...
Loading clinical trials...
Non-classified atypical squamous cells (ASCUS) is the most common abnormal cervical cytology (%39). The risk of cervical intraepithelial neoplasia 2-3 is 5% and the risk of carcinoma is around 0.1% af...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Collaborators
NCT03913117 · ASC-US, LSIL
NCT07407569 · Human Papilloma Virus Infection Type 16
NCT07214584 · Cervical Cancer, Human Papilloma Virus (HPV)
NCT05495906 · HPV, Human Papilloma Virus, and more
NCT04178174 · Head and Neck Cancer, Oropharynx Cancer, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions